account_balanceBalance Sheet (BS) Summary

Updated: 06/30/20262026 Q2

Total Assets

7.9M USD

YoY -43.0%

Shareholders' Equity

4.6M USD

YoY +439.1%

Equity Ratio

58.5%

YoY +52.3pt

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %

806040200

2021

2022

2023

2024

2025

Balance Sheet Details

Unit: USD

Item

2020

2021

2022

2023

2024

2025

Cash

Cash and Equivalents

Short-term Investments

Net Receivables

Inventory

Other Current Assets

Total Current Assets

4.89M

0

6.35M

Goodwill

Intangible Assets

Property, Plant and Equipment

Property, Plant and Equipment Net

Long-term Investments

Other Assets

Other Non-current Assets

Net Tangible Assets

Non-current Assets Total

Total Assets

0

3.22M

0

48,000

9.62M

3.27M

9.62M

Accounts Payable

Short-term Debt

Short/Current Long-term Debt

Current Deferred Revenue

Other Current Liabilities

Total Current Liabilities

945,000

0

108,000

1.76M

Long-term Debt

Long-term Debt Total

Capital Lease Obligations

Other Non-current Liabilities

Net Debt

Non-current Liabilities Total

Total Liabilities

0

2.41M

0

-2.48M

1.70M

3.46M

Common Stock

Common Stock Shares Outstanding

Additional Paid-in Capital

Retained Earnings

Accumulated Other Comprehensive Income

Other Stockholder Equity

Treasury Stock

Total Stockholder Equity

1,000

3.33M

60.32M

-54.16M

0

6.16M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan

FibroBiologics, Inc. Common Stock

account_balanceBalance Sheet (BS) Summary

Asset & Liability Mix

Equity Ratio Trend (5 Years)

Balance Sheet Details

Unlock Long-Term Balance Sheet Data